Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation.

Cited by papers we hold 10

• Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation · 2022
  No notice
• Protein kinase CK2: a potential therapeutic target for diverse human diseases · 2021
  No notice
• Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review · 2020
  No notice
• Autophagy in Neurodegenerative Diseases: A Hunter for Aggregates · 2020
  No notice
• The role of TDP-43 mislocalization in amyotrophic lateral sclerosis · 2020
  No notice
• Structural Insights Into TDP-43 and Effects of Post-translational Modifications · 2019
  Corrected
• The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD · 2019
  No notice
• TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets · 2015
  Corrected
• Differential roles of the ubiquitin proteasome system (UPS) and autophagy in the clearance of soluble and aggregated TDP-43 species · 2014
  No notice
• Protein aggregation in amyotrophic lateral sclerosis · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.